Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease
This study has been completed.
Information provided by (Responsible Party):
First received: May 20, 2008
Last updated: April 4, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2012|
|Primary Completion Date:||August 2011 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Ahimastos AA, Latouche C, Natoli AK, Reddy-luthmoodoo M, Golledge J, Kingwell BA. Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication. Circ Res. 2014 Mar 28;114(7):1144-55. doi: 10.1161/CIRCRESAHA.114.302420. Retraction in: Circ Res. 2015 Sep 11;117(7):e64.
Retraction in: Circ Res. 2015 Sep 11;117(7):e64
Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, Reid CM, Golledge J, Kingwell BA. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA. 2013 Feb 6;309(5):453-60. doi: 10.1001/jama.2012.216237. Retraction in: JAMA. 2015 Oct 13;314(14):1520-1.
Retraction in: JAMA. 2015 Oct 13;314(14):1520-1